
Yayınlanma: 20 Aralık 2020 18:38
Güncellenme: 28 Kasım 2025 10:46
On the way towards the long-awaited development, Tesla has seen a steep rise and gained almost 43 percent in the past 30 days. The share, which gained 5.96 percent on Friday, completed the day at the level of $ 695.
The company's inclusion in the index will bring billions of dollars in Tesla stock purchases to match the assets of the index funds following SPX to the index, which brought the share rise. Palo Alto, California-based electric car manufacturer, will be included in the index as the seventh largest company, with a market value of over $ 600 billion after a 700 percent rally this year.
Some of the reasons why Tesla soared in 2020 were the announcement of profitability for five consecutive quarters, the successful completion of a large factory in China, and the start of construction of a similar facility in Germany.
On the other hand, some analysts warned investors that Tesla shares had a serious risk of decline after the listing before entering the S&P 500 Index, and that there was no similar increase in the company's financial results despite the increase in the share price.
Moderna became the second company to obtain emergency use approval in the USA after the vaccine developed by Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX).
The vaccine produced by the company is the first product of Moderna, whose share is valued more than 600 percent this year. Moderna announced that the delivery of the vaccine to the relevant institutions in the US will begin immediately and an application for full approval is expected next year.
Sales revenues increased by 8.9 percent in the quarter ending on November 30, reaching $ 11.2 billion, while earnings per share, expected to be $ 0.62, reached $ 0.78.
Using the statements "We are in a time when strong brands are getting stronger.", CEO John Donahoe continued as follows:
"The permanent drive towards digital, sportswear and health continues to offer us an incredible opportunity."
Nike revised its forecast for 2021 as its sales recovered after the epidemic. The company announced that it expects a 10-15 percent year-over-year increase in sales revenue. Nike shares, which gained 35 percent this year, increased by more than 5 percent with the transactions following the closing and completed Friday at the level of 137.28 dollars.
Source: Investing.com




